4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alkem Laboratories Limited (ALKEM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 19,346 employees. Its market capitalization is roughly ₹654 billion. In the fiscal year ended 2026-03-31, ALKEM reported ₹145.3B in revenue and ₹23.0B in net income.
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹145.3B | ₹128.0B | ₹124.4B | ₹114.4B | — |
| Gross Profit | ₹93.3B | ₹79.5B | ₹74.1B | ₹64.6B | — |
| Operating Income (EBIT) | ₹26.5B | ₹21.8B | ₹19.8B | ₹13.3B | — |
| Net Income | ₹23.0B | ₹21.7B | ₹18.0B | ₹9.8B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | ₹37.4B | ₹36.0B | ₹37.4B | ₹40.0B | ₹33.7B |
| Gross Profit | ₹25.4B | ₹23.6B | ₹24.6B | ₹26.0B | ₹22.0B |
| Operating Income (EBIT) | ₹6.7B | ₹4.1B | ₹7.3B | ₹8.3B | ₹6.5B |
| Net Income | ₹5.2B | ₹2.4B | ₹6.4B | ₹7.7B | ₹6.6B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹6.1B) | (₹5.0B) | (₹5.4B) | (₹5.3B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹208.7B | ₹176.9B | ₹155.7B | ₹137.6B | — |
| Total Liabilities | ₹65.2B | ₹52.6B | ₹48.6B | ₹43.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALKEM viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms